Literature DB >> 35342473

Preoperative Therapeutic Plasma Exchange and Surgical Treatment in Thyrotoxicosis Patients: A Single-Centre Retrospective Cohort Study.

H Yabanoglu1, R Sari1, F Eksi Haydardedeoglu2, M Kus1, A S Hargura1, I M Arer1.   

Abstract

Context: Therapeutic plasma exchange (TPE) provides time for thyroidectomy in thyrotoxic patients. Objective: TPE is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and were subsequently operated for thyrotoxicosis. Design: The patients who underwent thyroidectomy and TPE between January 1999 and February 2019 were retrospectively analyzed. Subjects and
Methods: The files of 27 patients with thyrotoxicosis who performed TPE prior to surgery were analyzed in relation to the demographic and clinical features.
Results: We included 15 (55.6%) females, 12 (44.4%) males with a mean age of 44 (23-82) years. The pre-TPE mean free thyroxine (fT4) level was 12 (5-46) pmol/L while free tri-iodothyronine (fT3) level was 34 (17-141) pmol/L. The post-TPE fT4 level was 6 (3-10) pmol/L while the fT3 level was 21 (12-41). There was one case of an allergic reaction during the procedure. In the postoperative follow-up, there was transient hypocalcemia in 8 (29%) patients, permanent hypocalcemia in 1 (3.7%) patient, and surgical site infection in 1 (3.7%) patient.
Conclusion: Preoperative TPE is an alternative treatment option for thyrotoxic patients. This is an especially effective treatment for patients with inadequate response or adverse reaction to antithyroid drugs or patients who need urgent surgery for thyroid storm. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Graves’ disease; Therapeutic plasma exchange; Thyroid storm; Thyrotoxicosis

Year:  2021        PMID: 35342473      PMCID: PMC8919486          DOI: 10.4183/aeb.2021.346

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  24 in total

Review 1.  Management of thyrotoxicosis.

Authors:  Joseph N Fisher
Journal:  South Med J       Date:  2002-05       Impact factor: 0.954

Review 2.  Thyroid emergencies.

Authors:  Nicholas J Sarlis; Loukas Gourgiotis
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

3.  Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Authors:  Zbigniew M Szczepiorkowski; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Beth H Shaz; Robert Weinstein; Ashka Wirk; Jeffrey L Winters
Journal:  J Clin Apher       Date:  2007-06       Impact factor: 2.821

4.  [Treatment of severe hyperthyroidism by plasma exchange. Clinical and biological efficacy. 8 cases].

Authors:  J L Schlienger; A Faradji; R Sapin; J F Blickle; G Chabrier; C Simon; M Imler
Journal:  Presse Med       Date:  1985-06-08       Impact factor: 1.228

5.  Thyroid storm treatment with blood exchange and plasmapheresis.

Authors:  F S Ashkar; R B Katims; W M Smoak; A J Gilson
Journal:  JAMA       Date:  1970-11-16       Impact factor: 56.272

6.  STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery.

Authors:  Riaz Agha; Ali Abdall-Razak; Eleanor Crossley; Naeem Dowlut; Christos Iosifidis; Ginimol Mathew
Journal:  Int J Surg       Date:  2019-11-06       Impact factor: 6.071

7.  Complications of double-filtration plasmapheresis.

Authors:  Jiann-Horng Yeh; Wei-Hung Chen; Hou-Chang Chiu
Journal:  Transfusion       Date:  2004-11       Impact factor: 3.157

Review 8.  Management of amiodarone-induced thyrotoxicosis.

Authors:  Chinnadorai Rajeswaran; Rhidian John Shelton; Stephen George Gilbey
Journal:  Swiss Med Wkly       Date:  2003-11-22       Impact factor: 2.193

9.  The role of therapeutic plasmapheresis in patients with hyperthyroidism.

Authors:  Ozden Ozdemir Baser; Zeynep Cetin; Merve Catak; Derya Koseoglu; Dilek Berker
Journal:  Transfus Apher Sci       Date:  2020-03-18       Impact factor: 1.764

Review 10.  Perioperative management of the thyrotoxic patient.

Authors:  Roy W Langley; Henry B Burch
Journal:  Endocrinol Metab Clin North Am       Date:  2003-06       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.